Bank of America Securities said GoodRx’s long-term outlook will depend on how it adapts to a rapidly evolving prescription ...

Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 1.4% in the afternoon session after the stock's positive ...

Shares of GoodRx ($GDRX), which provides drug coupons for discounts on medications, jumped over 5% on Thursday afternoon.

GoodRx Holdings (GDRX) shares saw a dip today, closing down about 11%. While there was no material news event driving the move, it comes after a recent streak of strong gains over the past week. See ...

GoodRx GDRX recently rolled out a new e-commerce experience aimed at improving how consumers obtain their prescriptions through its platform. This upgraded system offers a more streamlined and ...

GoodRx stock rated a sell due to industry headwinds, cost growth outpacing revenue, and needing 12%+ growth to justify price. Q2 earnings expected to be in line with guidance, but long-term guidance ...

Ratings for GoodRx Holdings (NASDAQ:GDRX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...

GoodRx Holdings, Inc. seeks growth via Novo Nordisk and TrumpRx deals, boosting revenue per user. Click for more on ...

GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible ...